The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies

The increase in the number of therapeutic alternatives for both newly diagnosed and relapsed/refractory multiple myeloma (RRMM) patients has widened the clinical scenario, leading to a level of complexity that no algorithm has been able to cover up to date. At present, this complexity increases due...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Rivas, José-Ángel, Ríos-Tamayo, Rafael, Encinas, Cristina, Alonso, Rafael, Lahuerta, Juan-José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743063/
https://www.ncbi.nlm.nih.gov/pubmed/35000618
http://dx.doi.org/10.1186/s40364-021-00344-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743063/
https://www.ncbi.nlm.nih.gov/pubmed/35000618
http://dx.doi.org/10.1186/s40364-021-00344-2

Ejemplares similares